Adaptimmune Therapeutics Correlations

ADAP Stock

USD 0.73 0.05 7.35%

The current 90-days correlation between Adaptimmune Therapeutics and Black Diamond Therapeutics is 0.43 (i.e., Very weak diversification). The correlation of Adaptimmune Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Adaptimmune Therapeutics Correlation With Market

Modest diversification

The correlation between Adaptimmune Therapeutics Plc and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptimmune Therapeutics Plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Adaptimmune Stock

0.89	FDMT	4D Molecular Therapeutics	Pair Corr
0.74	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.87	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.67	INKT	Mink Therapeutics	Pair Corr
0.7	MREO	Mereo BioPharma Group	Pair Corr
0.9	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.76	PEPG	PepGen	Pair Corr
0.64	PIRS	Pieris Pharmaceuticals	Pair Corr
0.71	RGNX	Regenxbio	Pair Corr
0.73	AFMD	Affimed NV	Pair Corr
0.68	STOK	Stoke Therapeutics	Pair Corr
0.96	BDTX	Black Diamond Therap	Pair Corr
0.68	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Adaptimmune Stock

0.83	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.72	NAMS	NewAmsterdam Pharma	Pair Corr
0.58	PHVS	Pharvaris BV	Pair Corr
0.46	ESLAW	Estrella Immunopharma	Pair Corr
0.44	PMVP	Pmv Pharmaceuticals	Pair Corr
0.38	OPT	Opthea	Pair Corr
0.34	MNOV	MediciNova	Pair Corr
0.87	CRVS	Corvus Pharmaceuticals	Pair Corr
0.77	AVTE	Aerovate Therapeutics	Pair Corr
0.69	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.65	VREX	Varex Imaging Corp	Pair Corr
0.54	ABEO	Abeona Therapeutics	Pair Corr
0.47	AGIO	Agios Pharm	Pair Corr

Related Correlations Analysis

	STOK	FIXX	BDTX	HARP	MREO	PIRS	PDSB	LPTX	AFMD	CRVS
STOK		-0.23	0.74	-0.46	0.5	0.47	0.08	0.1	0.84	-0.48	STOK
FIXX	-0.23		0.1	0.22	0.06	-0.04	0.0	-0.71	-0.26	-0.36	FIXX
BDTX	0.74	0.1		-0.61	0.64	0.6	0.27	-0.19	0.77	-0.87	BDTX
HARP	-0.46	0.22	-0.61		-0.65	-0.65	-0.31	-0.24	-0.48	0.51	HARP
MREO	0.5	0.06	0.64	-0.65		0.57	0.65	0.03	0.58	-0.54	MREO
PIRS	0.47	-0.04	0.6	-0.65	0.57		0.19	0.24	0.54	-0.41	PIRS
PDSB	0.08	0.0	0.27	-0.31	0.65	0.19		0.03	0.21	-0.37	PDSB
LPTX	0.1	-0.71	-0.19	-0.24	0.03	0.24	0.03		0.2	0.48	LPTX
AFMD	0.84	-0.26	0.77	-0.48	0.58	0.54	0.21	0.2		-0.47	AFMD
CRVS	-0.48	-0.36	-0.87	0.51	-0.54	-0.41	-0.37	0.48	-0.47		CRVS
	STOK	FIXX	BDTX	HARP	MREO	PIRS	PDSB	LPTX	AFMD	CRVS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AFMD	+ 0.84	STOK
AFMD	+ 0.77	BDTX
BDTX	+ 0.74	STOK
PDSB	+ 0.65	MREO
MREO	+ 0.64	BDTX
PIRS	+ 0.6	BDTX

High negative correlations

CRVS	- 0.87	BDTX
LPTX	- 0.71	FIXX
PIRS	- 0.65	HARP
MREO	- 0.65	HARP
HARP	- 0.61	BDTX
CRVS	- 0.54	MREO

Risk-Adjusted Indicators

There is a big difference between Adaptimmune Stock performing well and Adaptimmune Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adaptimmune Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
STOK	2.62	(0.39)	0.00	(0.17)	0.00	0.00	4.68	(6.99)	21.35
FIXX	2.82	0.17	0.01	(0.59)	3.52	(3.25)	5.77	(5.61)	19.43
BDTX	3.49	(1.65)	0.00	(0.63)	0.00	0.00	5.47	(8.30)	19.51
HARP	3.55	0.38	0.11	0.37	3.28	(5.07)	9.59	(6.25)	22.48
MREO	2.67	(0.64)	0.00	(0.40)	0.00	0.00	4.80	(6.31)	17.36
PIRS	1.60	(0.17)	0.00	(0.14)	0.00	0.00	3.23	(3.40)	12.92
PDSB	3.33	(0.72)	0.00	(0.30)	0.00	0.00	7.67	(6.76)	31.83
LPTX	3.78	(0.08)	(0.02)	0.04	4.32	(4.35)	11.08	(7.03)	25.59
AFMD	2.71	(0.68)	0.00	(0.33)	0.00	0.00	7.25	(6.82)	21.26
CRVS	3.61	1.05	0.28	0.79	2.98	(4.20)	9.38	(4.88)	23.11

Adaptimmune Therapeutics Corporate Management

Kerry Sharp	Senior Council	Profile
Dennis Williams	Senior Development	Profile
Sbastien Desprez	VP Affairs	Profile
Dana Lynch	Senior Communications	Profile
Helen MBA	CoFounder Officer	Profile
Bertrand Esq	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC